Parkmore Medical Centre has provided 26,288 COVID-19 vaccine doses since March 2021*

From 20/02/2023, all adults who have not had a COVID-19 booster or a confirmed case in the past six months can now get another booster to give them additional protection against severe illness from COVID. Best done before June 2023.

We’re currently providing Pfizer Bivalent Comirnaty vaccine or Moderna Bivalent Spikevax vaccine

We also provide COVID-19 vaccine for children aged 6 months to under 5 years*

(only those who are severely immunocompromised, or have disability, as well as those who have complex and/or multiple health conditions that increase their risk of severe COVID-19 in this age group 6 months – 5 years)

Second dose of Pfizer or Moderna vaccine now recommended at 8 weeks

First booster (3rd) dose

recommended for adults >16 years at a minimum of 3 months after your second dose

adolescents aged 12-15 years with severe immunocompromised or complex, chronic or severe conditions (Pfizer booster in this age group only).

Second booster (4th) dose

recommended for adults >30 years at a minimum of 3 months after your 3rd dose

People aged 16-29 years who have complex, chronic or severe conditions

Third booster (5th) dose

adults >18 years at a minimum of 6 months after your 4th dose

The interval recommended between a recent SARS-CoV-2 infection or the booster dose is now 6 months.

We welcome new patients. All you need is a valid Medicare card. New patient please fill out registration form Here before ringing for your appointment

Consent form for Pfizer vaccine for adults can be downloaded Here and for children <12 can be downloaded Here

Please bring these to your appointment, otherwise they will provided for you on the day. Other languages also available Here

You may have questions about the COVID Vaccine, please have a read Here or make a clinic appointment prior to your injection. The allocated appointment is for your COVID-19 vaccination only

Once you’ve completed both doses, you can get your COVID-19 vaccination digital certificate Here

We look forward to welcome you to our clinic

updated 05/09/2022

ATAGI has recommended the Moderna COVID-19 vaccine for children aged 6 months to under 5 years who are severely immunocompromised, or have disability, as well as those who have complex and/or multiple health conditions that increase their risk of severe COVID-19.

These include children with the following or similar conditions:

Severe primary or secondary immunodeficiency, including those undergoing treatment for cancer, or on immunosuppressive treatments as listed in the ATAGI advice on 3rd primary doses of COVID-19 vaccine in individuals who are severely immunocompromised;
Bone marrow or stem cell transplant, or chimeric antigen T-cell (CAR-T) therapy;
Complex congenital cardiac disease;
Structural airway anomalies or chronic lung disease;
Type 1 diabetes mellitus;
Chronic neurological or neuromuscular conditions; or
A disability that requires frequent assistance with activities of daily living, such as severe cerebral palsy or Down Syndrome (Trisomy 21).

updated 07/07/2022

ATAGI has updated its recommendations for a winter dose of COVID-19 vaccine to help reduce severe disease from the emerging surge of Omicron BA.4 and BA.5 subvariant infections, and to reduce the burden on Australian hospitals and the healthcare system in coming months.

The updated recommendations are:

Adults aged 50 to 64 years are now recommended to receive a winter booster dose of a COVID-19 vaccine.
Adults aged 30 to 49 years can receive a winter booster dose of a COVID-19 vaccine, however the benefit for people in this age group is less certain.
The interval recommended between a recent SARS-CoV-2 infection or the first booster dose and a winter booster dose is now 3 months.

**updated 25/05/2022

Additional groups recommended (from 25 May 2022) for winter booster (4th dose)

• People aged 16-64 years who have complex, chronic or severe conditions that are considered to increase their risk of severe illness from COVID-19

**updated 25/03/2022

ATAGI recommends an additional booster dose of COVID-19 vaccine to increase vaccine protection for winter. This winter booster dose should be available from April 2022 for specified populations who are at increased risk of severe disease. These groups are:

Adults aged 65 years and older
Residents of aged care or disability care facilities (including those under 65 years)
People aged 16 years and older with severe immunocompromise as defined in the ATAGI statement on use of a 3^rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised)
Aboriginal and Torres Strait Islander adults aged 50 years and older.

The additional winter booster dose can be given from 3 months or longer after the person has received their first booster dose, or from 3 months after a confirmed SARS-CoV-2 infection, if infection occurred since the person’s first COVID-19 booster dose.

*updated 08/02/2023

COVID-19 Vaccination

Parkmore Medical Centre has provided 26,288 COVID-19 vaccine doses since March 2021*

From 20/02/2023, all adults who have not had a COVID-19 booster or a confirmed case in the past six months can now get another booster to give them additional protection against severe illness from COVID. Best done before June 2023.

We’re currently providing Pfizer Bivalent Comirnaty vaccine or Moderna Bivalent Spikevax vaccine

We also provide COVID-19 vaccine for children aged 6 months to under 5 years*

(only those who are severely immunocompromised, or have disability, as well as those who have complex and/or multiple health conditions that increase their risk of severe COVID-19 in this age group 6 months – 5 years)

Second dose of Pfizer or Moderna vaccine now recommended at 8 weeks

First booster (3rd) dose

recommended for adults >16 years at a minimum of 3 months after your second dose

adolescents aged 12-15 years with severe immunocompromised or complex, chronic or severe conditions (Pfizer booster in this age group only).

Second booster (4th) dose

recommended for adults >30 years at a minimum of 3 months after your 3rd dose

People aged 16-29 years who have complex, chronic or severe conditions

Third booster (5th) dose

adults >18 years at a minimum of 6 months after your 4th dose

The interval recommended between a recent SARS-CoV-2 infection or the booster dose is now 6 months.

We welcome new patients. All you need is a valid Medicare card. New patient please fill out registration form Here before ringing for your appointment

Consent form for Pfizer vaccine for adults can be downloaded Here and for children <12 can be downloaded Here

Please bring these to your appointment, otherwise they will provided for you on the day. Other languages also available Here

You may have questions about the COVID Vaccine, please have a read Here or make a clinic appointment prior to your injection. The allocated appointment is for your COVID-19 vaccination only

Once you’ve completed both doses, you can get your COVID-19 vaccination digital certificate Here

We look forward to welcome you to our clinic

updated 05/09/2022

ATAGI has recommended the Moderna COVID-19 vaccine for children aged 6 months to under 5 years who are severely immunocompromised, or have disability, as well as those who have complex and/or multiple health conditions that increase their risk of severe COVID-19.

These include children with the following or similar conditions:

Severe primary or secondary immunodeficiency, including those undergoing treatment for cancer, or on immunosuppressive treatments as listed in the ATAGI advice on 3rd primary doses of COVID-19 vaccine in individuals who are severely immunocompromised;

Bone marrow or stem cell transplant, or chimeric antigen T-cell (CAR-T) therapy;

Complex congenital cardiac disease;

Structural airway anomalies or chronic lung disease;

Type 1 diabetes mellitus;

Chronic neurological or neuromuscular conditions; or

A disability that requires frequent assistance with activities of daily living, such as severe cerebral palsy or Down Syndrome (Trisomy 21).

updated 07/07/2022

ATAGI has updated its recommendations for a winter dose of COVID-19 vaccine to help reduce severe disease from the emerging surge of Omicron BA.4 and BA.5 subvariant infections, and to reduce the burden on Australian hospitals and the healthcare system in coming months.

The updated recommendations are:

Adults aged 50 to 64 years are now recommended to receive a winter booster dose of a COVID-19 vaccine.

Adults aged 30 to 49 years can receive a winter booster dose of a COVID-19 vaccine, however the benefit for people in this age group is less certain.

The interval recommended between a recent SARS-CoV-2 infection or the first booster dose and a winter booster dose is now 3 months.

**updated 25/05/2022

Additional groups recommended (from 25 May 2022) for winter booster (4th dose)

• People aged 16-64 years who have complex, chronic or severe conditions that are considered to increase their risk of severe illness from COVID-19

**updated 25/03/2022

ATAGI recommends an additional booster dose of COVID-19 vaccine to increase vaccine protection for winter. This winter booster dose should be available from April 2022 for specified populations who are at increased risk of severe disease. These groups are:

Adults aged 65 years and older

Residents of aged care or disability care facilities (including those under 65 years)

People aged 16 years and older with severe immunocompromise as defined in the ATAGI statement on use of a 3rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised)

Aboriginal and Torres Strait Islander adults aged 50 years and older.

The additional winter booster dose can be given from 3 months or longer after the person has received their first booster dose, or from 3 months after a confirmed SARS-CoV-2 infection, if infection occurred since the person’s first COVID-19 booster dose.

People aged 16 years and older with severe immunocompromise as defined in the ATAGI statement on use of a 3^rd primary dose of COVID-19 vaccine in individuals who are severely immunocompromised)